These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 14765557)

  • 1. The effect of lipoprotein-associated cyclosporine on drug metabolism and toxicity in rats.
    Kim T; Lu SK; Brunner LJ
    PDA J Pharm Sci Technol; 2003; 57(6):410-24. PubMed ID: 14765557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-density lipoprotein associated cyclosporine on hepatic metabolism and renal function.
    Kim T; Callahan SM; Wasan KM; Brunner LJ
    PDA J Pharm Sci Technol; 2003; 57(5):341-50. PubMed ID: 14677627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma distribution of cyclosporine within lipoproteins and "in vitro" transfer between very-low-density lipoproteins, low-density lipoproteins, and high-density lipoproteins.
    Hughes TA; Gaber AO; Montgomery CE
    Ther Drug Monit; 1991 Jul; 13(4):289-95. PubMed ID: 1780959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effect of various doses of cyclosporin A on plasma lipoproteins and its distribution in blood: an experimental study.
    Andrade RJ; Lucena MI; Gonzalez-Correa JA; Garcia-Arias C; Gonzalez-Santos P
    Hum Exp Toxicol; 1993 Mar; 12(2):141-6. PubMed ID: 8096712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol.
    Gälman C; Angelin B; Rudling M
    Endocrinology; 2002 May; 143(5):1809-16. PubMed ID: 11956163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lipoproteins on cyclosporine A toxicity and uptake in LLC-PK1 pig kidney cells.
    Peteherych KD; Wasan KM
    J Pharm Sci; 2001 Sep; 90(9):1395-406. PubMed ID: 11745792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cyclosporine and methylprednisolone on plasma lipoprotein levels in rats.
    Espino A; Lopez-Miranda J; Blanco-Cerrada J; Zambrana JL; Aumente MA; Paniagua JA; Blanco-Molina A; Jimenez-Pereperez JA; Rodriguez M; Pérez-Jiméz F
    J Lab Clin Med; 1995 Feb; 125(2):222-7. PubMed ID: 7844470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of sulphated polysaccharides in abating the hyperlipidemic nephropathy provoked by cyclosporine A.
    Josephine A; Veena CK; Amudha G; Preetha SP; Varalakshmi P
    Arch Toxicol; 2007 May; 81(5):371-9. PubMed ID: 17019561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid transfer protein I facilitated transfer of cyclosporine from low- to high-density lipoproteins is only partially dependent on its cholesteryl ester transfer activity.
    Wasan KM; Ramaswamy M; Wong W; Pritchard PH
    J Pharmacol Exp Ther; 1998 Feb; 284(2):599-605. PubMed ID: 9454803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporine A on the binding affinity and internalization of low-density lipoproteins in human skin fibroblasts.
    Wasan KM; Donnachie EM; Seccombe DW; Pritchard PH
    J Pharm Sci; 2002 Dec; 91(12):2520-4. PubMed ID: 12434395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
    Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
    Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low and high density lipoproteins on renal cyclosporine A and cyclosporine G disposition in the isolated perfused rat kidney.
    Strong ML; Ueda CT
    Pharm Res; 1997 Oct; 14(10):1466-71. PubMed ID: 9358563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications in low-density lipoprotein receptor expression affects Cyclosporin A cellular uptake and cytotoxicity.
    Leon C; Jia J; Qiu G; Hill JS; Wasan KM
    J Pharm Sci; 2008 Jun; 97(6):2350-61. PubMed ID: 17823952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
    Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
    J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K
    Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cyclosporine on low-density lipoprotein uptake in human lymphocytes.
    Ruiu G; Pinach S; Gambino R; Uberti B; Alemanno N; Pagano G; Cassader M
    Metabolism; 2005 Dec; 54(12):1620-5. PubMed ID: 16311095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractions.
    Luke DR; Brunner LJ; Lopez-Berestein G; Yau JC
    J Pharm Sci; 1992 Mar; 81(3):208-11. PubMed ID: 1640354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat.
    Liao W; Rudling M; Angelin B
    Endocrinology; 1997 May; 138(5):1863-70. PubMed ID: 9112380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients.
    Venkiteswaran K; Sgoutas DS; Santanam N; Neylan JF
    Transpl Int; 2001 Dec; 14(6):405-10. PubMed ID: 11793038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.